Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio’s Investigational Compound Being Developed for Patients with AMLInvivoscribe Marketing2022-08-16T20:08:13+00:00August 16th, 2022|2022 Press Releases, Press Releases| Read more
A Comprehensive Solution for AML Precision DiagnosticsInvivoscribe Marketing2022-08-02T14:52:04+00:00July 20th, 2022|2022 Videos, 2022 Webinars, Featured Videos, Videos| Watch video
Next-generation sequencing of immunoglobulin genes in lymphoid malignanciesInvivoscribe Marketing2022-05-25T03:00:57+00:00May 19th, 2022|2022 Videos, Featured Videos, Videos| Watch video
Corporate OverviewInvivoscribe Marketing2022-05-25T03:00:57+00:00March 10th, 2022|2022 Videos, Featured Videos, Videos| Watch video
Lab Secrets: Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS)Invivoscribe Marketing2022-05-25T03:00:57+00:00February 24th, 2022|2022 Videos, Featured Videos, Videos| Watch video
Review of Guidelines for Interpreting Somatic Hypermutation Status in Chronic Lymphocytic Leukemia in the Era of High-Throughput SequencingInvivoscribe Marketing2022-05-25T03:00:57+00:00January 26th, 2022|2022 Videos, Featured Videos, Videos| Watch video
Global Standardization of Flow Cytometry Results with AI SystemsInvivoscribe Marketing2022-05-25T03:00:57+00:00December 8th, 2021|2021 Videos, 2021 Webinars, Featured Videos, Videos, Webinars| Watch video
Explore the Benefits, Considerations, and Utility of NGS B- and T-cell ClonalityInvivoscribe Marketing2022-05-25T03:00:57+00:00October 28th, 2021|2021 Videos, 2021 Webinars, Featured Videos, Videos, Webinars| Watch video
EAHP-SH 2022Invivoscribe Marketing2022-04-15T00:09:30+00:00September 17th, 2021|Conferences| Read more
Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline UseInvivoscribe Marketing2021-09-02T16:53:40+00:00September 2nd, 2021|2021 Press Releases, Press Releases| Read more
Critical Mistakes to Avoid when Developing a Drug/CDx Combination for International RegistrationsInvivoscribe Marketing2022-05-25T03:00:58+00:00August 24th, 2021|2021 Videos, Featured Videos, Videos| Watch video
Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in ChinaInvivoscribe Marketing2021-07-22T17:27:56+00:00July 22nd, 2021|2021 Press Releases, Press Releases| Read more
A Streamlined Laboratory Workflow for Controlling Antibody and Reagent Lots on a 12C Flow Cytometry SystemInvivoscribe Marketing2022-05-25T03:00:58+00:00July 15th, 2021|2021 Videos, 2021 Webinars, Featured Videos, Videos, Webinars| Watch video
Japanese Association of Molecular Target Therapy of Cancer 2022Invivoscribe Marketing2022-04-15T00:09:44+00:00June 29th, 2021|Conferences| Read more
Assessment of MRD by NGS in Daily Clinical Management of Multiple MyelomaInvivoscribe Marketing2022-05-25T03:00:58+00:00June 14th, 2021|2021 Videos, Featured Videos, Videos| Watch video
New Frontiers in Hematology: From CLL Tumor Precursor Cells to Tracking Disease Burden in Multiple MyelomaInvivoscribe Marketing2022-05-25T03:00:58+00:00June 14th, 2021|2021 Videos, Featured Videos, Videos| Watch video